Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, Not Recruiting

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

NCT04322955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • The Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Irving Medical Center New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

NCT04960709

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Research Site Orange, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 196 locations
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

NCT03092856

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details
Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details

Related conditions